We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Gel-Free ECG System to Transform Heart Health Diagnosis

By HospiMedica International staff writers
Posted on 17 Dec 2025

Electrocardiogram monitoring is essential for detecting heart rhythm disorders, yet current systems rely on disposable gel-based electrodes that can dry out, fall off, and generate significant medical waste. More...

The process is often uncomfortable for patients and requires manual interpretation by clinicians, slowing diagnosis and limiting long-term monitoring. Now, a new wearable approach has demonstrated that heart signals can be captured comfortably, reused safely, and analyzed automatically to support faster and more accessible arrhythmia detection.

The system, developed by researchers at Simon Fraser University (Burnaby, BC, Canada), integrates reusable dry electrodes produced through 3D printing and embedded into a soft, adjustable chest belt intended for extended wear. Each electrode uses an origami-inspired suction structure that gently adheres to the skin without adhesives. Carbon-based conductive ink replaces traditional electrolyte gel, transmitting cardiac electrical signals to a wearable unit equipped with artificial intelligence (AI) software capable of pre-screening multiple types of heart rhythm abnormalities.

Evaluation of the technology showed that the dry electrodes performed with accuracy comparable to conventional gel-based ECG sensors while improving ease of use and patient comfort. In findings published in Biosensors and Bioelectronics, nurses reported that the belt-based system could improve compliance during long-term monitoring, which is typically performed using bulky Holter monitors. If an electrode loses contact, users can simply press the origami structure to restore suction rather than replacing patches or reapplying gel.

With arrhythmias expected to affect one in three people globally and atrial fibrillation rates projected to rise sharply, the system could support scalable and personalized heart monitoring. Its reusable design may reduce waste and costs while enabling deployment in emergency rooms, hospital wards, senior care facilities, and remote or underserved communities. The team plans to further refine the AI algorithm and reduce the physical size of the electrode to improve wearability. Future iterations are expected to enhance early detection and remote sharing of results with physicians for confirmation.

“Current ECG testing relies on single-use sticky patches and gel, which can dry out and fall off, and then the data must be manually interpreted by a doctor,” said Professor Woo Soo Kim, who led the research. “Our dry electrodes are just as accurate as gel-based sensors, but they’re more comfortable for patients, easier to use, and they can be sanitized and reused to significantly reduce waste.”

Related Links:
Simon Fraser University 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.